Korean patients with systemic lupus erythematosus (SLE) face a greater risk of autoimmune thyroid disease, a nationwide population-based study using health insurance claims data showed. The study, “Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based study in Korea,” recently appeared in the journal PLoS…
Lupus patients with a history of kidney disease, but now in remission, should not be advised against a wanted pregnancy — even if they show serologic activity, or positive anti-double-stranded DNA antibodies and low complement levels (C4), results from the PROMISSE trial show. Women in the study based on these findings, “…
A recent 12-year follow-up study performed on first-degree relatives (FDRs) of patients with systemic lupus erythematosus (SLE) showed an increased frequency of autoantibodies such as anti-nuclear antibodies (ANA) when compared to healthy controls. The study, “Autoantibodies persist in relatives to systemic lupus erythematosus patients during 12 years follow-up,” was published…
A new and unusual study describes a three- to 32-year follow-up analysis of systemic lupus erythematosus (SLE) patients to understand the number who achieve complete remission (three years) and subsequently remain in remission. The study, titled “Analysis of Complete Remission in Lupus Patients over a period of 32 years,”…
A research team has recently showed that the natural product astilbin can diminish disease development in mice susceptible to lupus by decreasing functional activated T and B cells. The study entitled “Decrease of Functional Activated T and B Cells and Treatment of Glomerulonephitis in Lupus-Prone Mice Using a Natural Flavonoid…
A new study showed that mice deficient in regulatory T cells develop systemic autoimmune disease similar to lupus. The study entitled “Regulatory T cell deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease” was published in Arthritis Research & Therapy. Scurfy mice do…